Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.61% is 49% below its 5-year average of 7.08%, near the low end of its 5-year range (0.94%–15.90%).
As of the fiscal period ended Wednesday, December 31, 2025. 3.60% below its 12-month average of 3.75%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
3.61%
RETURN ON ASSETS (ROA) AVG TTM
3.75%
RETURN ON ASSETS (ROA) AVG 3Y
6.08%
RETURN ON ASSETS (ROA) AVG 5Y
7.08%
RETURN ON ASSETS (ROA) AVG 10Y
7.27%
RETURN ON ASSETS (ROA) AVG 15Y
6.02%
RETURN ON ASSETS (ROA) AVG 20Y
5.57%
CURRENT VS TTM AVG
-3.60%
CURRENT VS 3Y AVG
-40.65%
CURRENT VS 5Y AVG
-49.00%
CURRENT VS 10Y AVG
-50.33%
CURRENT VS 15Y AVG
-40.05%
CURRENT VS 20Y AVG
-35.14%
SECTOR MEDIAN · HEALTHCARE
4.91%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-26.48%
vs the sector median at left
Pfizer Inc.
Market Cap
$142.54B
Return on Assets (ROA)
3.61%
TTM Avg
3.75%
3Y Avg
6.08%
5Y Avg
7.08%
Market Cap
$137.13B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$133.37B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$133.25B
Return on Assets (ROA)
1.16%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$131.47B
Return on Assets (ROA)
9.11%
TTM Avg
7.88%
3Y Avg
6.26%
5Y Avg
4.99%
Market Cap
$124.86B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$124.82B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$161.66B
Return on Assets (ROA)
16.38%
TTM Avg
7.62%
3Y Avg
7.90%
5Y Avg
6.83%
Market Cap
$121.09B
Return on Assets (ROA)
16.38%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pfizer Inc. (PFE) | $142.54B | 3.61% | 3.75% | 6.08% | 7.08% |
| Danaher Corporation (DHR)vs › | $137.13B | 4.33% | 4.68% | 5.89% | 6.01% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 10.59% | -0.92% | 3.28% | 1.99% |
| CVS Health Corp. (CVS)vs › | $133.25B | 1.16% | 1.25% | 1.93% | 2.38% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 9.11% | 7.88% | 6.26% | 4.99% |
| Stryker Corporation (SYK)vs › | $124.86B | 7.78% | 6.88% | 7.02% | 6.41% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 15.04% | 13.09% | 12.00% | 11.68% |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 16.38% | 7.62% | 7.90% | 6.83% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 16.38% | 6.37% | 11.74% | 14.58% |
| Medtronic plc (MDT)vs › | $109.30B | 5.16% | 5.13% | 4.62% | 4.65% |
ROA
3.6%
ROE
8.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.73% |
| 2024-12-31 | 3.76% |
| 2023-12-31 | 0.94% |
| 2022-12-31 | 15.90% |
| 2021-12-31 | 12.20% |
| 2020-12-31 | 5.94% |
| 2019-12-31 | 9.72% |
| 2018-12-31 | 7.00% |
| 2017-12-31 | 12.40% |
| 2016-12-31 | 4.20% |
| 2015-12-31 | 4.16% |
| 2014-12-31 | 5.36% |
| 2013-12-31 | 6.77% |
| 2012-12-31 | 5.27% |
| 2011-12-31 | 4.63% |
| 2010-12-31 | 4.24% |
| 2009-12-31 | 4.05% |
| 2008-12-31 | 7.22% |
| 2007-12-31 | 7.12% |
| 2006-12-31 | 9.60% |
| 2005-12-31 | 6.47% |
| 2004-12-31 | 9.16% |
| 2003-12-31 | 3.35% |
| 2002-12-31 | 19.69% |
| 2001-12-31 | 19.89% |
| 2000-12-31 | 11.12% |
| 1999-12-31 | 15.45% |
| 1998-12-31 | 18.31% |
| 1997-12-31 | 14.43% |
| 1996-12-31 | 13.15% |
